The emerging role of non-coding RNA in essential hypertension and blood pressure regulation

Journal of Human Hypertension

Volumn 29, Issue 8, 2015, Pages 459-467

  Marques, F Z ^a   Booth, S A ^a   Charchar, F J ^a  

^a UNIVERSITY OF BALLARAT   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; UNTRANSLATED RNA; LONG UNTRANSLATED RNA;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CELLS BY BODY ANATOMY; CORONARY ARTERY DISEASE; ESSENTIAL HYPERTENSION; GENE EXPRESSION; GENETIC CODE; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN CYTOMEGALOVIRUS; HYPERTENSION; IN VITRO GENE TRANSFER; REGULATOR GENE; REVIEW; RNA EXTRACTION; SINGLE NUCLEOTIDE POLYMORPHISM; STEM CELL; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE CELL; BINDING SITE; BLOOD; BLOOD PRESSURE; GENETIC POLYMORPHISM; GENETICS; PHYSIOLOGY; URINE;

BINDING SITES; BLOOD PRESSURE; HUMANS; HYPERTENSION; MICRORNAS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, LONG NONCODING; RNA, UNTRANSLATED;

EID: 84936846922     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2014.99     Document Type: Review

References (51)

1. Munroe PB, Barnes MR, Caulfield MJ. Advances in blood pressure genomics. Circ Res 2013; 112(10): 1365-1379.
2. Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011; 478(7367): 103-109.
3. Mattick JS. Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep 2001; 2(11): 986-991.
4. Frith MC, Pheasant M, Mattick JS. The amazing complexity of the human transcriptome. Eur J Hum Genet 2005; 13(8): 894-897.
5. Thomas JW, Touchman JW, Blakesley RW, Bouffard GG, Beckstrom-Sternberg SM, Margulies EH, et al. Comparative analyses of multi-species sequences from targeted genomic regions. Nature 2003; 424(6950): 788-793.
6. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011; 12(12): 861-874.
7. Pasquinelli AE. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet 2012; 13(4): 271-282.
8. Da Sacco L, Masotti A. Recent insights and novel bioinformatics tools to understand the role of microRNAs binding to 5′ untranslated region. Int J Mol Sci 2012; 14(1): 480-495.
9. Kozomara A, Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 2014; 42, Database issue D68-D73.
10. Zampetaki A, Willeit P, Drozdov I, Kiechl S, Mayr M. Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovasc Res 2012; 93 (4): 555-562.
11. Tijsen AJ, Pinto YM, Creemers EE. Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases.Am J Physiol Heart Circ Physiol 2012; 303(9): H1085-H1095.
12. Eisenberg E, Levanon EY. Human housekeeping genes, revisited. Trends Genet 2013; 29(10): 569-574.
13. Li S, Zhu J, Zhang W, Chen Y, Zhang K, Popescu LM, et al. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation 2011; 124(2): 175-184.
14. Karolina DS, Tavintharan S, Armugam A, Sepramaniam S, Pek SL, Wong MT, et al. Circulating miRNA profiles in patients with metabolic syndrome. J Clin Endocrinol Metab 2012; 97(12): E2271-E2276.
15. Gu Q, Wang B, Zhang XF, Ma YP, Liu JD, Wang XZ. Contribution of reninangiotensin system to exercise-induced attenuation of aortic remodeling and improvement of endothelial function in spontaneously hypertensive rats. Cardiovasc Pathol 2014; 23(5): 298-305.
16. Penzkofer D, Bonauer A, Fischer A, Tups A, Brandes RP, Zeiher AM, et al. Phenotypic characterization of miR-92a -/- mice reveals an important function of miR-92a in skeletal development. PLoS ONE 2014; 9(6): e101153.
17. Gildea JJ, Carlson JM, Schoeffel CD, Carey RM, Felder RA. Urinary exosome miRNome analysis and its applications to salt sensitivity of blood pressure. Clin Biochem 2013; 46(12): 1131-1134.
18. Kontaraki JE, Marketou ME, Zacharis EA, Parthenakis FI, Vardas PE. Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension. J Hum Hypertens 2014; 28(8): 510-516.
19. Kontaraki JE, Marketou ME, Zacharis EA, Parthenakis FI, Vardas PE. MicroRNA-9 and microRNA-126 expression levels in patients with essential hypertension: potential markers of target-organ damage. J Am Soc Hypertens 2014; 8(6): 368-375.
20. Mandraffino G, Imbalzano E, Sardo MA, D'Ascola A, Mamone F, Lo Gullo A, et al. Circulating progenitor cells in hypertensive patients with different degrees of cardiovascular involvement. J Hum Hypertens 2014; 28(9): 543-550.
21. Williams Z, Ben-Dov IZ, Elias R, Mihailovic A, Brown M, Rosenwaks Z, et al. Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations. Proc Natl Acad Sci USA 2013; 110(11): 4255-4260.
22. Hindson CM, Chevillet JR, Briggs HA, Gallichotte EN, Ruf IK, Hindson BJ, et al. Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods 2013; 10(10): 1003-1005.
23. Marques FZ, Campain AE, Tomaszewski M, Yang YHJ, Zukowska-Sczechowska E, Charchar FJ, et al. Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs. Hypertension 2011; 58: 1093-1098.
24. Tomaszewski M, Charchar FJ, Lynch MD, Padmanabhan S, Wang WY, Miller WH, et al. Fibroblast growth factor 1 gene and hypertension: from the quantitative trait locus to positional analysis. Circulation 2007; 116(17): 1915-1924.
25. Tomaszewski M, Charchar FJ, Nelson CP, Barnes T, Denniff M, Kaiser M, et al. Pathway analysis shows association between FGFBP1 and hypertension. Journal of the American Society of Nephrology: JASN 2011; 22(5): 947-955.
26. Davern PJ, Nguyen-Huu TP, La Greca L, Abdelkader A, Head GA. Role of the sympathetic nervous system in Schlager genetically hypertensive mice. Hypertension 2009; 54(4): 852-859.
27. Jackson KL, Marques FZ, Watson AM, Palma-Rigo K, Nguyen-Huu TP, Morris BJ, et al. A novel interaction between sympathetic overactivity and aberrant regulation of renin by miR-181a in BPH/2J genetically hypertensive mice. Hypertension 2013; 62(4): 775-781.
28. Eskildsen TV, Jeppesen PL, Schneider M, Nossent AY, Sandberg MB, Hansen PB, et al. Angiotensin II regulates microRNA-132/-212 in hypertensive rats and humans. Int J Mol Sci 2013; 14(6): 11190-11207.
29. Santovito D, Mandolini C, Marcantonio P, De Nardis V, Bucci M, Paganelli C, et al. Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients. Expert Opin Ther Targets 2013; 17(3): 217-223.
30. Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, Elton TS, et al. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3′ untranslated region: a mechanism for functional singlenucleotide polymorphisms related to phenotypes. Am J Hum Genet 2007; 81(2): 405-413.
31. Ceolotto G, Papparella I, Bortoluzzi A, Strapazzon G, Ragazzo F, Bratti P, et al. Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives. Am J Hypertens 2011; 24(2): 241-246.
32. Elton TS, Sansom SE, Martin MM. Cardiovascular disease, single nucleotide polymorphisms, and the renin angiotensin system: is there a microRNA connection? Int J Hypertens 2010; 2010(2010): 281692.
33. Nossent AY, Hansen JL, Doggen C, Quax PH, Sheikh SP, Rosendaal FR. SNPs in microRNA binding sites in 3′-UTRs of RAAS genes influence arterial blood pressure and risk of myocardial infarction. Am J Hypertens 2011; 24(9): 999-1006.
34. Yang Z, Venardos K, Jones E, Morris BJ, Chin-Dusting J, Kaye DM. Identification of a novel polymorphism in the 3′ UTR of the L-arginine transporter gene SLC7A1: contribution to hypertension and endothelial dysfunction. Circulation 2007; 115 (10): 1269-1274.
35. Yang Z, Kaye DM. Mechanistic insights into the link between a polymorphism of the 3′UTR of the SLC7A1 gene and hypertension. Hum Mutat 2009; 30(3): 328-333.
36. Wang L, Rao F, Zhang K, Mahata M, Rodriguez-Flores JL, Fung MM, et al. Neuropeptide Y(1) Receptor NPY1R discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo. J Am Coll Cardiol 2009; 54(10): 944-954.
37. O'Connor DT, Zhu G, Rao F, Taupenot L, Fung MM, Das M, et al. Heritability and genome-wide linkage in US and Australian twins identify novel genomic regions controlling chromogranin a: implications for secretion and blood pressure. Circulation 2008; 118(3): 247-257.
38. Wei Z, Biswas N, Wang L, Courel M, Zhang K, Soler-Jover A, et al. A common genetic variant in the 3′-UTR of vacuolar H+-ATPase ATP6V0A1 creates a microRNA motif to alter chromogranin A processing and hypertension risk. Circ Cardiovasc Genet 2011; 4(4): 381-389.
39. Arora P, Wu C, Khan AM, Bloch DB, Davis-Dusenbery BN, Ghorbani A, et al. Atrial natriuretic peptide is negatively regulated by microRNA-425. J Clin Invest 2013; 123(8): 3378-3382.
40. Hanin G, Shenhar-Tsarfaty S, Yayon N, Hoe YY, Bennett ER, Sklan EH, et al. Competing targets of microRNA-608 affect anxiety and hypertension. Hum Mol Genet 2014; 23(17): 4569-4580.
41. Fu X, Guo L, Jiang ZM, Zhao LS, Xu AG. An miR-143 promoter variant associated with essential hypertension. Int J Clin Exp Med 2014; 7(7): 1813-1817.
42. Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 2013; 495(7441): 333-338.
43. Leung A, Trac C, Jin W, Lanting L, Akbany A, Saetrom P, et al. Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells. Circ Res 2013; 113(3): 266-278.
44. Hirt MN, Hansen A, Eschenhagen T. Cardiac tissue engineering: state of the art. Circ Res 2014; 114(2): 354-367.
45. Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, et al. Natural RNA circles function as efficient microRNA sponges. Nature 2013; 495 (7441): 384-388.
46. Juan L, Wang G, Radovich M, Schneider BP, Clare SE, Wang Y, et al. Potential roles of microRNAs in regulating long intergenic noncoding RNAs. BMC Med Genomics 2013; 6(Suppl 1): S7.
47. Friese RS, Altshuler AE, Zhang K, Miramontes-Gonzalez JP, Hightower CM, Jirout ML, et al. MicroRNA-22 and promoter motif polymorphisms at the Chga locus in genetic hypertension: functional and therapeutic implications for gene expression and the pathogenesis of hypertension. Hum Mol Genet 2013; 22(18): 3624-3640.
48. Sahu BS, Sonawane PJ, Mahapatra NR., Chromogranin A. a novel susceptibility gene for essential hypertension. Cell Mol Life Sci 2010; 67(6): 861-874.
49. Wahlquist C, Jeong D, Rojas-Munoz A, Kho C, Lee A, Mitsuyama S, et al. Inhibition of miR-25 improves cardiac contractility in the failing heart. Nature 2014; 508 (7497): 531-535.
50. Iaconetti C, Gareri C, Polimeni A, Indolfi C. Non-coding RNAs: the "dark matter" of cardiovascular pathophysiology. Int J Mol Sci 2013; 14(10): 19987-20018.
51. Gupta SK, Piccoli MT, Thum T. Non-coding RNAs in cardiovascular ageing. Ageing Res Rev 2014; 17C: 79-85.